Antibodies that reacted with plasma membranes of human eye muscle but showed no binding to plasma membranes of human skeletal muscle were identified in serum of patients with Graves'
Introduction
The aetiology of Graves' ophthalmopathy is not fully understood, but substantial evidence indicates that it is a separate organ specific autoimmune disorder. Though cell mediated immunity seems to be well documented,i 2 the presence of specific autoantibodies directed against retro-orbital antigens has only recently been reported. Kodama et al showed serum autoantibodies reacting with soluble antigens isolated from human eye muscle cytosol.3 Kendall-Taylor et al also showed autoantibodies in the serum of patients with severe infiltrating ophthalmopathy that specifically react with antigens localised in porcine eye muscle membranes. 4 In the present study we measured antihuman eye muscle plasma membrane antibodies in the serum of patients with Graves' ophthalmopathy, using the ability of protein A from Staphylococcuts aiureus to interact with the Fc fragment of IgG. We also attempted to study the possible correlation between these autoantibodies and antihuman thyroid membrane antibodies and antithyroglobulin antibodies.
Patients and methods

PATIENTS
We studied 20 patients (seven men, 13 women) aged 22-70 with infiltrating Graves' ophthalmopathy. The severity of the eye signs ranged from class 2 to class 6 in the classification of the American Thyroid Association.5 At the time of the study five patients were hyperthyroid, nine were euthyroid but had been hyperthyroid in the (1 g/1) was first preincubated with 50 ul serum for two hours at 37cC and then left overnight at 4°C. After preincubation 1 ml phosphate buffer was added and the tubes mixed and centrifuged at 10 000 g for 10 minutes at 4°C. The supernatant was discarded and the pellet washed with 1 ml cold buffer. Eye muscle plasma membranes preincubated with serum (100 yg protein) were then incubated with 125I protein A (50 000 cpm) for two hours at 4 C. The reaction was stopped by adding 1 ml cold phosphate buffer, and samples were centrifuged at 10 000 g for 10 minutes at 4°C. The 
Results
Values of the antihuman eye muscle plasma membrane antibody index in patients with Graves' ophthalmopathy varied from 0-81 to 2 17 and in controls from 0 53 to 1 55 (fig 1) . The upper limit of normal for the index was therefore chosen as 1-55. The mean index in patients and controls was significantly different (1-66 (SE 0-33) v 1-00 (0 29), p 0 001).
When human skeletal muscle plasma membranes were used as a source of antigen no significant difference in antihuman eye muscle plasma membrane antibody index was found between the patients with Graves' ophthalmopathy and the controls (1 04 (0 22) v 1 00 (0 11)).
To exclude a possible role of thvroglobulin in the binding of antihuman eye muscle plasma membrane antibodies to putative antigens, preincubation mixtures of pooled serum from patients and from BRITISH MEDICAL JOURNAL VOLUME 290 19 JANUARY 1985 191 controls were enriched with rabbit antithyroglobulin antibodies at dilutions from 1 x 10-3 to 20 x 10-3. At these dilutions the thyroglobulin antibodies had no effect on 1251 protein A binding to membranes preincubated with serum from either the patients or the controls (fig 2) . To investigate whether antibodies against eye muscle plasma membranes and thyroid plasma membranes represent the same type of IgG the antihuman eye muscle plasma membrane antibody and antihuman thyroid membrane antibody indexes obtained in the same patients were compared, but no correlation could be demonstrated (r=-0 07). Similarly, there was no correlation between the antihuman eye muscle plasma membrane antibody index and titres of thyroglobulin antibodies in the same patients (r =0-22).
Discussion
Using the ability of protein A to interact with Fc fragment of IgG we were able to show the presence of antibodies that react with human eye muscle plasma membranes in most patients with Graves' ophthalmopathy. We also showed that these antibodies are specific as they did not react with human skeletal muscle plasma membranes. The presence of such antibodies was recently reported by Kendall-Taylor et al, who also emphasised their *high specificity. 4 We detected these antibodies in 14 (70°0) of patients with Graves' ophthalmopathy. Similar results were obtained by Kodama et al, who used soluble human eye muscle antigens to investigate specific antibodies and obtained positive results in 75' of patients studied.3 Two possibilities might explain the "negative" values of the antihuman eye muscle plasma membrane antibody index in some of our patients. As some of the patients had a long history of eye disease they may possibly have achieved an immunological remission. Alternatively, a negative index might be due to the relatively low sensitivity of the assay as a result of using tissues obtained at necropsy.
In 4 In our previous studies we have shown that antithyroid plasma membrane antibodies are present in almost all patients with Graves' disease. 13 The lack of correlation between indexes of antihuman eye muscle plasma membrane antibodies and antihuman thyroid membrane antibodies in individual patients with Graves' ophthalmopathy also provides support for the possibility that ophthalmopathy is an independent autoimmune disorder.. Further studies are necessary to investigate the possible correlations of the level of orbital antibodies with the duration of the eye disease and with the severity of the disease.
